NanoTag - an IgG-free method for mapping DNA-protein interactions

Maria A Dimitriu,Rodrigo G Arzate-Mejia,Leonard C Steg,Pierre-Luc Germain,Isabelle M Mansuy
DOI: https://doi.org/10.1101/2024.07.12.603224
2024-07-12
Abstract:Genome-wide profiling of DNA-protein interactions in cells can provide important information about mechanisms of gene regulation. Most current methods for genome-wide profiling of DNA-bound proteins, such as ChIP-seq and CUT&Tag, use conventional IgG antibodies to bind target protein(s), which limits their applicability to targets for which high affinity and high specificity antibodies are available. Here we describe NanoTag, a novel method derived from CUT&Tag that is IgG-free and uses a nanobody to profile DNA-protein interactions. NanoTag is based on an anti-GFP nanobody-Tn5 transposase fusion that allows mapping GFP-tagged proteins associated with chromatin in a fast and cost-effective manner. We demonstrate the utility of NanoTag by profiling the histone mark H3K4me3 via its binding partner TATA box-binding protein-associated factor 3 (TAF3) and the transcription factors Nanog and CTCF in mouse embryonic stem cells expressing GFP-tagged targets. For the targets examined, NanoTag data shows high correlation to CUT&Tag data and displays a similarly high signal-to-noise ratio. Overall, NanoTag provides a flexible, IgG-free and cost-effective method to generate high resolution DNA-binding profiles in cells or tissues.
Molecular Biology
What problem does this paper attempt to address?
The article proposes a new method called NanoTag for mapping DNA-protein interactions in the absence of IgG antibodies. Traditional methods such as ChIP-seq and CUT&Tag rely on high-affinity and high-specificity IgG antibodies to bind to target proteins, limiting their application to targets lacking suitable antibodies. NanoTag directly targets GFP-tagged proteins that bind to chromatin by binding to nanobodies fused with the Tn5 transposase enzyme. This provides a fast, cost-effective way to generate high-resolution DNA-binding protein profiles in cells or tissues. Researchers applied NanoTag in mouse embryonic stem cells (mESCs) and successfully analyzed histone modification H3K4me3 mapped by its binding partner TAF3, as well as binding sites of GFP-tagged Nanog and CTCF transcription factors. The experimental results showed a high correlation between NanoTag data and CUT&Tag data, with a high signal-to-noise ratio. The advantages of this method include its flexibility, independence from IgG antibodies, cost-effectiveness, suitability for low-input chromatin characterization, and use of a short and direct protocol. Comparatively, NanoTag demonstrated performance comparable to CUT&Tag in mapping TAF3, Nanog, and CTCF, despite some technical differences such as peak-calling strategies that may affect overlapping results. NanoTag also showed applicability across different input materials (fresh cells, fresh or frozen nuclei) and can be extended to identify endogenous targets directly, such as using nanobodies or other antibody mimetics targeting chromatin-associated proteins. In conclusion, NanoTag provides an attractive alternative for high-throughput analysis of DNA-binding proteins or epigenetic marks lacking high-quality IgG antibodies, contributing to a better understanding of gene regulatory mechanisms.